Skip to main content

MINI REVIEW article

Front. Endocrinol., 22 August 2022
Sec. Cellular Endocrinology
This article is part of the Research Topic The Link Between Metabolic Syndrome and Chronic Kidney Disease: Focus on Diagnosis And Therapeutics View all 12 articles

Primary cilium in kidney development, function and disease

  • 1Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China
  • 2Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China

The primary cilium is a hair-like, microtubule-based organelle that is covered by the cell membrane and extends from the surface of most vertebrate cells. It detects and translates extracellular signals to direct various cellular signaling pathways to maintain homeostasis. It is mainly distributed in the proximal and distal tubules and collecting ducts in the kidney. Specific signaling transduction proteins localize to primary cilia. Defects in cilia structure and function lead to a class of diseases termed ciliopathies. The proper functioning of primary cilia is essential to kidney organogenesis and the maintenance of epithelial cell differentiation and proliferation. Persistent cilia dysfunction has a role in the early stages and progression of renal diseases, such as cystogenesis and acute tubular necrosis (ATN). In this review, we focus on the central role of cilia in kidney development and illustrate how defects in cilia are associated with renal disease progression.

Introduction

Cilium emanates from the mother centriole, and it is classified into motile cilia (9 + 2 structure) and nonmotile cilia (9 + 0 structure). Motile cilia have nine peripheral doublets of microtubules with a central pair complex (9 + 2), and primary cilia lack the centrally located pair (9 + 0) (1, 2). In vertebrates, cilia are widely distributed. Motile cilia are distributed on the surface of cells of the cerebral ventricle, respiratory mucosa, and reproductive system, and primary cilia are mainly distributed in embryos, kidneys and retina. They play fundamental roles in the asymmetric development of organs, mucus clearance of the respiratory tract, hearing, neurogenesis, and sperm motility (37).

The cilia life cycle is tightly related to the cell cycle (811) and consists of cilium assembly and cilia disassembly. The diverse roles of the primary cilium depend on the well-established balance between cilia assembly and disassembly (Figure 1). Cilia assembly is a precise and orderly multistep process. In the absence of mitogen or stimulation by differentiation signals, cells escape from the mitotic phase and enter the G0 phase. Then, cilia begin to assemble. First, within a few minutes of mitogen deprivation, vehicles originating from the Golgi or recycling endosomes, distal appendage vesicle (DAV), cluster at the distal appendage of the mother centriole (MC). This initiates the conversion from MC to the basal body, building a platform for cilia assembly. DAVs aggregate and fuse at the mother centriole to form the ciliary vesicle (CV) (12). CV formation marks the maturation of the basal body. The distal accessory structure protein Cep164 helps to maintain the integrity of this structure and anchors its fusion with the ciliary vehicle by binding to the GTP enzymes Rab8 and Rabin8 (13, 14). In the second step of cilia assembly, Cep164 recruits TTBK2 to the mother centriole. Proper localization of TTBK2 is required for the disappearance of the key repressor CP110 from the mother centriole, which thereby recruits the intraflagellar transport protein (IFT) complex. This complex is responsible for bidirectional protein cargo transport along axonal microtubules and thus promotes axoneme assembly (13, 15, 16). In this process, kinesin 2 carries the cargo from the tip to the base of the cilium, while dynein functions in cargo transport on the opposite side. After CV maturation, the transition zone (TZ) begins to assemble. It then embeds into and enlarges the CV. Subsequently, the ciliary axoneme is wrapped by CV and extends longitudinally. It is covered by the ciliary sheath, and finally fuses with the cell membrane. Ultimately, the mature ciliary composition includes axonemes composed of microtubules and associated proteins, the ciliary membrane connected to the cell membrane, and various matrices between the axonemes and the membrane (8).

FIGURE 1
www.frontiersin.org

Figure 1 The ciliary life cycle is in tune with the cell cycle. Ciliogenesis occurs in the G0/early G1 phase or differentiation stage. Each stage of the cell cycle is as indicated (G1, S, G2 and M phase), and blue and orange arrows indicate cilium assembly and disassembly, respectively. The mother centriole (light blue cylinder) can initiate ciliogenesis (cilium assembly). (1) Distal appendage vehicles (DAVs, dark blue triangles) accumulate near the distal appendage of the mother centriole. (2) DAVs aggregate and fuse with the mother centriole, forming a ciliary vehicle. (3) Assembly of the transition zone (TZ). (4) The ciliary axoneme (indicated by parallel green rods) covered by CV elongates vertically and fuses with the cell membrane. (5) Extension of the ciliary axoneme and membrane. These microtubule structures disassemble as cells progress to S phase. Several key signaling pathways that mediate cilia disassembly are summarized in the box. During the later S phase, centrosomes begin to duplicate. After mitosis, centrosomes set out to assemble primary cilia.

Compared to cilium assembly, the signaling pathways for cilia disassembly are poorly understood (17). The Aurora A-HDAC6 and Nek2-Kif24 pathways and actin polymerization are the key signaling pathways that can induce cilia disassembly. It is widely accepted that Aurora A is the major pathway for the direct induction of ciliary microtubule deacetylation through the activation of HDAC6 (18). Nek2 ensures Kif24 activation in cells that lack cilia, and Nek2 is mainly expressed during the S and G2 phases (19). Imbalance between cilium assembly and disassembly leads to the loss of cell cycle regulation, and the loss of cilia may be an initiating factor of the oncogenesis of renal cancer, melanoma, and breast, pancreatic and prostate cancer (2022).

Cilia in kidney development and function

Ciliary membranes are rich in receptors and ion channels that can be activated by mechanical or chemical stimuli (23). The proper spatiotemporal localization of receptors and the coordinated transportation of related signal modules that localize to the cilium lay the foundation for cilia sensory function (1, 24). The cilium is an important nexus for Hedgehog signaling, Wnt signaling, GPCR signaling and transforming growth factor-β (TGF-β)/bone morphogenetic protein (BMP) signaling (1, 25, 26). In nephrogenesis, Wnt signaling is of great importance (26). The Wnt signaling branches to β-catenin-dependent (canonical) and β-catenin-independent (noncanonical) pathway.

Wnt9b is expressed in the stalk of the ureteric bud (UB) as it invades and branches into the metanephric mesenchyme (MM) and acts as a paracrine signal to induce the expression of tubulogenic pathway markers, such as fibroblast growth factor-8 (FGF8), Wnt4 and Pax8 (27).. Wnt9b is required for the planar cell polarity (PCP) signaling pathway (28). Wnt4 was detected in condensing mesenchyme, pre-tubular aggregates (Figure 2) (29). Inactivation of FGF8 block formation of Wnt4-expressing pre-tubular aggregates, which led to S-shaped bodies, the precursor of nephron cannot develop (30, 31). Wnt9b and Wnt4 primarily employ the canonical, β-catenin-dependent pathway. Studies have shown that β-catenin activation is necessary and sufficient to initiate the tubulogenic program and induce MM in Wnt9b-/- and Wnt4-/- mice. However, it is important to maintain a proper balance of canonical Wnt signaling activity, and constitutive β-catenin activation results in cyst formation in all tubular segments (32). Ksp-cre conditional inactivation of APC, which enhances β-catenin activity, results in cystic kidneys in all tubular segments and a hyperproliferative epithelium (33). Module component jouberin (JBN)-deficient mice show cystic kidneys and malformations of the central nervous system caused by dysregulated Wnt-β-catenin signaling (34).

FIGURE 2
www.frontiersin.org

Figure 2 Molecular control of early kidney development. Wnt9b is expressed in ureteric bud and turns on differentiation markers FGF8, Wnt4 and Pax8 via β-catenin pathway. These cells form the pre-tubular aggregate highlighted by the expression of critical differentiation factors Pax8 FGF8 and Wnt4.

Simon et al. suggested that Wnt functions primarily via β-catenin-dependent pathways in the absence of flow (35). Flow sensing by the primary cilium is thought to function as a switch from canonical pathway to noncanonical pathway (Figure 3). Studies have suggested that the primary cilium inhibit the activity of canonical Wnt signaling (perhaps promoting noncanonical signaling pathway) in mouse embryos, primary fibroblasts and embryonic stem cells (36).

FIGURE 3
www.frontiersin.org

Figure 3 Fluid flow flip the switch from canonical to noncanonical Wnt signaling pathway. In the absence of flow, ligand binding with the Frizzled and LRP5/6 complex results in the inactivation of the β-catenin destruction complex (GSK3β, CK1, APC, Axin), led to stabilization of cytoplasmic β-catenin, which translocate to nucleus and coactivate the transcription level of LEF-TCF family. Fluid flow stimulated primary cilia, which is thought to increase the expression of inversin (INVS) and then reduce the cytoplasmic levels of dishevelled (DVL) by increasing its proteasomal degradation pathway. This process is deemed as switch off canonical signal pathway due to the activation of β-catenin destruction complex. The question mark indicate uncertainty as to the INVS-DVL complexes localization. The dotted box mark indicate that whether β-catenin is phosphorylated and ubiquitylated within the cilium is unknown.

Activation of GPCR signaling, functionally coupled to calcium channels, led to an increase in calcium concentration in the cilia, and cilium was lengthened by mediating actin depolymerization (1). TGF-β signaling induces the shortening of primary cilia in mouse renal tubular epithelial cells (RTECs) and is related to epithelial and mesenchymal transition (37).

In addition, shear stress stimulates lipophagy and mitochondrial biogenesis in RTECs to produce fatty acids that provide substrates for mitochondrial β-oxidation to generate ATP. This ensures an energy supply for the reabsorption of glucose in RTECs, and this process is dependent on the primary cilium (38). Unilateral ureteral obstruction (UUO) in mice reduced fluid flow, and the authors found defects in lipophagy. These defects resulted in lipid droplet accumulation in kidney cortical cells, intensifying the central role of the primary cilium in sensing mechanical stress to regulate mitochondrial activity and lipophagy (38). Miceli and Roccio et al. hypothesized that the primary cilium–autophagy axis plays a key role in the response to shear stress induced by fluid flow (3941).

Mutations leading to ciliary structure and function defects give rise to multiple organ-involved disorders termed ciliopathies (4244). These ciliopathies are accompanied by the following phenotypes: retinal degradation, hearing loss, malformation of the central nervous system, and polycystic kidney (45, 46). The significance of the renal cilium is reinforced by the fact that defects in this organelle lead to polycystic kidney disease, Meckel-Gruber syndrome (MKS), Bardet–Biedl syndrome (BBS), nephronophthisis (NPHP) and renal cell carcinoma (RCC) (5, 4548) (Table 1).

TABLE 1
www.frontiersin.org

Table 1 Cilia phenotype in kidney disease.

Cystic kidney disease

Cystic kidney diseases are classified into two broad groups (49): (1) polycystic kidney disease (PKD), which includes autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD), is characterized by large, polycystic kidneys; (2) the group of hereditary cystic diseases with interstitial nephritis that are characterized by small- to normal-size kidneys with tubular atrophy and interstitial fibrosis, including nephronophthisis (NPHP), Bardet-Biedl syndrome (BBS), and Meckel-Gruber syndrome (MKS). The cysts are lined by epithelial cells and filled with fluid and amorphous material.

Polycystic kidney disease

ADPKD is a genetic disease with a prevalence of 1:1000; it is caused by mutations in PKD1 and PKD2 (50). PKD1 and PKD2 encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively. Colocalization of GPCR PC1 and ion channel PC2 mediates flow-sensitive mechanotransduction in primary cilia and responds to flow by increasing calcium influx (51). Loss of cilia causes PC1 and PC2 to fail to localize to cilia to perform their functions. This results in excessive proliferation and enlargement of kidney epithelial cells, leading to polycystic kidneys. Inactivation of Pkd1 and other ciliary proteins in adult animals can cause cystic disease. This suggests that cilia are required not only for proper kidney development but also for maintenance of normal function and morphology (52).

ARPKD occurs mainly in infants and young children, with a prevalence of 1:20,000 (53). It is caused by mutations in PKHD1 and is characterized by cystic dilatations predominantly of the collecting duct. PKHD1 encodes polyductin/fibrocystin (PD).

Cystic diseases with interstitial nephritis

Nephronophthisis (NPHP) is an autosomal recessive disease that accounts for 10%-20% of cases of renal failure in children. It is characterized by cystic kidney tubules and interstitial fibrosis with inflammatory infiltrate. NPHP-related genes (NPHP1, NPHP2/inversin, NPHP3, NPHP4, NPHP5, NPHP6/CEP290, NPHP7/GLS2, NPHP8/RPGRIP1L, NPHP9/NEK8) have been implicated in NPHP. Unidentified mutated genes still need to be explored in 70% of cases (54).

BBS is a rare autosomal recessive syndrome characterized by postaxial polydactyly, retinitis pigmentosa, intellectual disability, obesity, hypogonadism in men, and a variety of renal abnormalities that include cysts, calyceal clubbing and blunting, tubulointerstitial nephropathy, and dysplastic kidneys. More than 12 genes have been implicated in BBS.

Alström syndrome is a rare autosomal recessive disease caused by mutations in ALMS1. It is mainly characterized by retinitis pigmentosa, hearing loss, insulin resistance, and obesity in children. In adult patients, the presentation of hyalinization of tubules and interstitial fibrosis in kidneys are observed. The ALMS1 protein is located at the base of cilia and centrosomes.

Primary cilium and cystic kidney disease

The first functional evidence linking primary cilium to cystic disease was derived from Caenorhabditis elegans IFT88 and its mouse homologue, polycystic kidney disease gene tg737 mutant mice. Ift88Orpk/Orpk (Tg737) mutant mice have shorter and blunted primary cilia in collecting ducts (55). Genetic repairment of Ift88-/- cells may possibly restore ciliary length and normalize ciliary function. The Kif3A conditional knockout mouse model also suggests that cystic disease can result from disrupting ciliary function and increasing canonical Wnt-β-catenin activity (36, 56). Evidence linking ciliary function to kidney cyst formation and PCP signaling was demonstrated using Ift20 Hoxb7Cre conditional mice (57). Wnt signaling activation and a misoriented axis of cell division account for cyst formation. Ksp-Cre; Wnt9b mutant mice have few cysts at P1 but many at P10. This is mainly because of a misoriented and random mitotic axis along the tubule in mutants compared to controls, suggesting that the Wnt9b mutant links noncanonical Wnt signaling to cyst formation (28). In summary, these findings support that defective PCP signaling plays a key role in cyst formation during kidney development. However, how these processes deregulate cellular orientation to prompt cystogenesis remains elusive.

An overwhelming abundance of data linking to cilia to cystic kidney disease but the causal relationships between them still need to be defined. A possible explanation for the primary cilia anomalies that cause cyst formation is that ciliogenesis is a multistep process. In this process, the NPHP complex, BBSome and over 20 cystoproteins are localized to the centrosome or the base body of cilium (58, 59), and any gene mutation that causes a loss/gain of function leads to defective ciliogenesis. It disables the function of the canonical Wnt-β-catenin or noncanonical Wnt-PCP signaling pathway, or certain proteins fail to localize to the cilium to induce downstream signaling pathways. Such disruptions lead to the overproliferation of epithelial cells and cystogenesis. Recently Hansen et al. elucidated the contribution of ciliary-derived cAMP signalosome to renal cystogenesis, ciliary cAMP signaling activates mTOR signaling and drives cell proliferation, countering the level of cAMP inhibits cyst formation (60). The study unravels a new molecular mechanism promoting PKD and provides new therapeutic targets to the treatment of PKD.

Acute kidney injury

Acute kidney injury (AKI) is a clinical syndrome of rapid decline in kidney function over a short period of time (a few hours or days), resulting in the retention of metabolic waste products, urea and creatinine (61, 62). Acute tubular necrosis (ATN) represents only one of multiple causes of AKI; it results largely from ischemia–reperfusion injury (IRI) (62). Deficiency of cilia promotes TGF-β-induced EMT and exacerbates the signaling under its pro-fibrotic signals (37), so restoring cilium length or occurrence may be a promising therapeutic target to anti-fibrosis in IRI. Cilia are critical for epithelial repair in renal IRI, indicating a relationship between the change in cilium length and sensitivity in the altered environment of the injured kidney (63, 64).

Elizabeth Verghese et al. identified that acute tubular necrosis causes an increase in the length of renal cilia, modifying their sensory sensitivity during repair (63). Biopsies from human renal transplants suffering ATN showed a dramatic increase in cilium length at 7 days post transplantation and a trend toward the normalization of cilium length at the later stage. A mouse model of ischemia–reperfusion injury (IRI) showed a similar trend. There was an increase in renal cilium length 1 week post-IRI and a return to normalization at 6 weeks. In addition, Jee In Kim et al. reported that the average length of the cilium in the proximal tubule initially shortened after IRI, and the length of cilia increased at 4 and 7 days, facilitating the initiation of the repair mechanism (64). Thus, we summarized the role of the renal cilium in response to injury and repair of damaged tubular epithelial cell reconstruction.

Primary glomerular disease

Focal segmental glomerulosclerosis (FSGS) is a pathologic diagnostic term that is mainly characterized by sclerosis of part of the glomerular (focal) or part of the glomerular capillary loops (segmental) (65). Evelyne Huynh Cong et al. reported that a homozygous missense mutation in the ciliary gene TTC21B causes familial primary FSGS, and knockdown of the TTC21B gene product IFT139 in podocytes leads to primary cilia defects and abnormal cell migration (66). Nevertheless, mutations of the ciliary gene TTC21B that lead to primary FSGS indicate a novel cilia function in primary glomerulus disease.

Ivana Solic et al. recently summarized the length of the primary cilium between healthy control and pathologically-changed kidney tissues, including FSGS, CSF and MCDK. In MCDK, CNF and FSGS, cilia were significantly elongated compared to healthy controls (67).

There are still many cilia-related phenotypes and functions that need to be explored in the near future in IgA nephropathy and membranous nephropathy.

Secondary kidney disease

Lupus nephritis

Lupus nephritis represents the most severe clinical manifestation of systemic lupus erythematosus (SLE) and leads to a high percentage of morbidity and mortality in patients. The etiology of SLE is characterized by interactions between genetic susceptibility, immune system abnormalities and hormone regulation disorders that result in tolerance disorders and sustained autoantibody production (68). Numerous 9 + 2 cilia and atypical 8 + 2 pattern cilia were found in the kidney biopsy from a patient with lupus nephritis, suggesting that the frequent occurrence of cilia in the lupus kidney results from metabolic and chemical derangements (69).

Diabetic kidney disease

Diabetic kidney disease (DKD) is one of the most serious complications of diabetes and has become the most common cause of ESRD worldwide (70). Studies have suggested that the pathogenesis of DKD includes an early increase in glomerular ultrafiltrate velocity leading to an increase in mechanical force in the renal tubule lumen, damage to and reduction in podocytes, thickening of the glomerular basement membrane, and expansion of the mesangial membrane (71, 72). Glomerular hyperfiltration is the initial factor contributing to kidney disease in diabetes (71). The high glucose environment also stimulates the activation of the following metabolic pathways (73): (1) the pentose phosphate pathway; (2) the polyol pathway; (3) the hexosamine pathway; (4) the protein kinase C (PKC) pathway; and (5) the advanced glycation end (AGE) pathway. Subsequently, ROS, diglyceride, pyruvaldehyde and lactic acid accumulate and cause cell damage (74). These changes in energy supply and metabolites are collectively termed metabolic reprogramming. A recent study showed that shear stress is transmitted into the cell via “antennas” on the surface of RTECs and primary cilia, which direct the metabolic reprogramming of cells to adapt to the environment (38). However, the function of primary cilia in diabetic kidney disease is still unknown.

The primary cilium of RTECs is an important mechanical force sensor for the shear stress, regulates the energy metabolism homeostasis in RTECs to ensure the energy supply for reabsorption function (38). Diabetic kidney disease is characterized by an increase in luminal shear stress induced by a high ultrafiltrate flow rate originating from the glomerulus. we hypothesized that elongated cilium were observed in the RTECs from DKD. It has been shown that glomerular expression of Sirtuin-1 (SIRT1), an NAD+-dependent protein/histone deacetylase, is reduced in human diabetic glomeruli (75), the expression and acetylation of HDAC6 is regulated by Sirt1 (76), so expression of HDAC6 exhibit down-regulated and activity of tubulin deacetylation was inhibited, so we speculated that glomerular hyperfiltration induced the key cilia disassembly regulator HDAC6 down-regulation, promoting cilium elongation and accelerates the progression of diabetic kidney disease. Lipid nanoparticles targeting renal cilium to remote control of cilia movement will be a possible therapeutic target to the diabetic kidney disease.

Renal cell carcinoma

In patients with RCC with mutations in the VHL (von Hippel–Lindau disease tumor suppressor) gene, primary cilia have been lost, and the re-expression of VHL proteins restored cilia occurrence (77). Ciliogenesis is inhibited in many types of cancer, including renal cell carcinoma (78), prostate cancer (79), pancreatic cancer (80), breast cancer and ovarian cancer (81, 82). Primary cilia are essential for Hedgehog signaling activation during development (1). Abnormal activation of Hedgehog can lead to a variety of tumorigenesis (8385). The importance of cilium loss in tumorigenesis, maintenance, and progression, as well as chemotherapeutic resistance emerged, which suggesting that restoration of primary cilia in tumor cells may be a potential therapeutic approach.

Ciliary-targeted therapy technology

Since proper cilium assembly and disassembly are required for embryogenesis and organ function, agents regulating cilia-associated proteins to control cilium length and number may become promising treatments for ciliopathy. The need to develop specific cilia-targeted treatments is urgent. Rajasekharreddy Pala. et al. designed an iron oxide nanoparticle-based and cilia-targeted delivery system to deliver agents specifically to the primary cilia, The hearts of ciliopathic displayed hypertrophy with declined functions in left ventricle because of prolonged hypertension. Magnetic field or fluid flow control cilia and then lead to the increase of Intraciliary and cytosolic Ca2+. The CT-Fe2O3-NPs significantly improved cardiac function in the ciliopathic hypertensive models (86).. Techniques for tissue-specific mRNA delivery and CRISPR-Cas gene editing nanoparticles have been developed (87), so we can specifically rescue the compromised cilia phenotype in ciliopathy by tissue-specific gene editing.

Histone deacetylase 6 (HDAC6), a cytoplasmic enzyme, is the major driver of cilium disassembly, and small molecules that inhibit HDAC6 have been demonstrated to restore the ciliary defective phenotype (8890). Anti-proliferating agents could also be candidates for polycystic kidney disease due to defective cilia-induced cell overproliferation. In addition, tissue-specific mRNA delivery and the CRISPR-Cas gene editing system could be applied to edit cilia-related genes and may be possible therapeutic targets for ciliopathies.

Conclusions

In summary, the primary cilium is the center platform that regulates diverse developmental signaling pathways, and its function relies on the control of the precise dynamic balance between cilia assembly and disassembly. More details of these signaling pathways and their involvement in kidney disease remain to be explored. How cilia sense mechanical stimuli is still an ongoing research topic. Ciliary-targeted technology urgently needs to be developed. Insights into ciliary defects in kidney disease will help us identify therapeutic targets for kidney injury relief and provide novel insights into disease mechanisms and ciliopathy intervention.

Author contributions

YB conceptualized and wrote the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the National Natural Science Foundation of China (Grant No. 32141005 and 82070741).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Anvarian Z, Mykytyn K, Mukhopadhyay S, Pedersen LB, Christensen ST. Cellular signalling by primary cilia in development, organ function and disease. Nat Rev Nephrol (2019) 15(4):199–219. doi: 10.1038/s41581-019-0116-9

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Satir P, Christensen ST. Overview of structure and function of mammalian cilia. Annu Rev Physiol (2007) 69:377–400. doi: 10.1146/annurev.physiol.69.040705.141236

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Vogel TW, Carter CS, Abode-Iyamah K, Zhang Q, Robinson S. The role of primary cilia in the pathophysiology of neural tube defects. Neurosurg Focus (2012) 33(4):E2. doi: 10.3171/2012.6.FOCUS12222

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Youn YH, Han YG. Primary cilia in brain development and diseases. Am J Pathol (2018) 188(1):11–22. doi: 10.1016/j.ajpath.2017.08.031

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Badano JL, Mitsuma N, Beales PL, Katsanis N. The ciliopathies: an emerging class of human genetic disorders. Annu Rev Genomics Hum Genet (2006) 7:125–48. doi: 10.1146/annurev.genom.7.080505.115610

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Narita K, Takeda S. Cilia in the choroid plexus: their roles in hydrocephalus and beyond. Front Cell Neurosci (2015) 9:39. doi: 10.3389/fncel.2015.00039

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Gerdes JM, Davis EE, Katsanis N. The vertebrate primary cilium in development, homeostasis, and disease. Cell (2009) 137(1):32–45. doi: 10.1016/j.cell.2009.03.023

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Hsu KS, Chuang JZ, Sung CH. The biology of ciliary dynamics. Cold Spring Harb Perspect Biol (2017) 9(4). doi: 10.1101/cshperspect.a027904

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Quarmby LM, Parker JD. Cilia and the cell cycle? J Cell Biol (2005) 169(5):707–10. doi: 10.1083/jcb.200503053

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Goto H, Inoko A, Inagaki M. Cell cycle progression by the repression of primary cilia formation in proliferating cells. Cell Mol Life Sci (2013) 70(20):3893–905. doi: 10.1007/s00018-013-1302-8

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Izawa I, Goto H, Kasahara K, Inagaki M. Current topics of functional links between primary cilia and cell cycle. Cilia (2015) 4:12. doi: 10.1186/s13630-015-0021-1

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Lu Q, Insinna C, Ott C, Stauffer J, Pintado PA, Rahajeng J, et al. Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation. Nat Cell Biol (2015) 17(3):228–40. doi: 10.1038/ncb3109

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Schmidt KN, Kuhns S, Neuner A, Hub B, Zentgraf H, Pereira G. Cep164 mediates vesicular docking to the mother centriole during early steps of ciliogenesis. J Cell Biol (2012) 199(7):1083–101. doi: 10.1083/jcb.201202126

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Westlake CJ, Baye LM, Nachury MV, Wright KJ, Ervin KE, Phu L, et al. Primary cilia membrane assembly is initiated by Rab11 and transport protein particle II (TRAPPII) complex-dependent trafficking of Rabin8 to the centrosome. Proc Natl Acad Sci U S A (2011) 108(7):2759–64. doi: 10.1073/pnas.1018823108

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Cajanek L, Nigg EA. Cep164 triggers ciliogenesis by recruiting tau tubulin kinase 2 to the mother centriole. Proc Natl Acad Sci U S A (2014) 111(28):E2841–50. doi: 10.1073/pnas.1401777111

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Spektor A, Tsang WY, Khoo D, Dynlacht BD. Cep97 and CP110 suppress a cilia assembly program. Cell (2007) 130(4):678–90. doi: 10.1016/j.cell.2007.06.027

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Liang Y, Meng D, Zhu B, Pan J. Mechanism of ciliary disassembly. Cell Mol Life Sci (2016) 73(9):1787–802. doi: 10.1007/s00018-016-2148-7

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent aurora a activation induces disassembly of the primary cilium. Cell (2007) 129(7):1351–63. doi: 10.1016/j.cell.2007.04.035

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Kim S, Lee K, Choi JH, Ringstad N, Dynlacht BD. Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle. Nat Commun (2015) 6:8087. doi: 10.1038/ncomms9087

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Mans DA, Voest EE, Giles RH. All along the watchtower: is the cilium a tumor suppressor organelle? Biochim Biophys Acta (2008) 1786(2):114–25. doi: 10.1016/j.bbcan.2008.02.002

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Jenks AD, Vyse S, Wong JP, Kostaras E, Keller D, Burgoyne T, et al. Primary cilia mediate diverse kinase inhibitor resistance mechanisms in cancer. Cell Rep (2018) 23(10):3042–55. doi: 10.1016/j.celrep.2018.05.016

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Yuan K, Frolova N, Xie Y, Wang D, Cook L, Kwon YJ, et al. Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues. J Histochem Cytochem (2010) 58(10):857–70. doi: 10.1369/jhc.2010.955856

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Rosenbaum JL, Witman GB. Intraflagellar transport. Nat Rev Mol Cell Biol (2002) 3(11):813–25. doi: 10.1038/nrm952

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Christensen ST, Pedersen SF, Satir P, Veland IR, Schneider L. The primary cilium coordinates signaling pathways in cell cycle control and migration during development and tissue repair. Curr Top Dev Biol (2008) 85:261–301. doi: 10.1016/S0070-2153(08)00810-7

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Bangs F, Anderson KV. Primary cilia and mammalian hedgehog signaling. Cold Spring Harb Perspect Biol (2017) 9(5). doi: 10.1101/cshperspect.a028175

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Gerdes JM, Katsanis N. Ciliary function and wnt signal modulation. Curr Top Dev Biol (2008) 85:175–95. doi: 10.1016/S0070-2153(08)00807-7

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Carroll TJ, Park JS, Hayashi S, Majumdar A, McMahon AP. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell (2005) 9(2):283–92. doi: 10.1016/j.devcel.2005.05.016

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Karner CM, Chirumamilla R, Aoki S, Igarashi P, Wallingford JB, Carroll TJ. Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nat Genet (2009) 41(7):793–9. doi: 10.1038/ng.400

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Stark K, Vainio S, Vassileva G, McMahon AP. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by wnt-4. Nature (1994) 372(6507):679–83. doi: 10.1038/372679a0

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Perantoni AO, Timofeeva O, Naillat F, Richman C, Pajni-Underwood S, Wilson C, et al. Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development (2005) 132(17):3859–71. doi: 10.1242/dev.01945

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Grieshammer U, Cebrian C, Ilagan R, Meyers E, Herzlinger D, Martin GR. FGF8 is required for cell survival at distinct stages of nephrogenesis and for regulation of gene expression in nascent nephrons. Development (2005) 132(17):3847–57. doi: 10.1242/dev.01944

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Saadi-Kheddouci S, Berrebi D, Romagnolo B, Cluzeaud F, Peuchmaur M, Kahn A, et al. Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene (2001) 20(42):5972–81. doi: 10.1038/sj.onc.1204825

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Qian CN, Knol J, Igarashi P, Lin F, Zylstra U, Teh BT, et al. Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium. J Biol Chem (2005) 280(5):3938–45. doi: 10.1074/jbc.M410697200

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Lancaster MA, Louie CM, Silhavy JL, Sintasath L, Decambre M, Nigam SK, et al. Impaired wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy. Nat Med (2009) 15(9):1046–54. doi: 10.1038/nm.2010

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Simons M, Gloy J, Ganner A, Bullerkotte A, Bashkurov M, Kronig C, et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between wnt signaling pathways. Nat Genet (2005) 37(5):537–43. doi: 10.1038/ng1552

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Corbit KC, Shyer AE, Dowdle WE, Gaulden J, Singla V, Chen MH, et al. Kif3a constrains beta-catenin-dependent wnt signalling through dual ciliary and non-ciliary mechanisms. Nat Cell Biol (2008) 10(1):70–6. doi: 10.1038/ncb1670

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Han SJ, Jung JK, Im SS, Lee SR, Jang BC, Park KM, et al. Deficiency of primary cilia in kidney epithelial cells induces epithelial to mesenchymal transition. Biochem Biophys Res Commun (2018) 496(2):450–4. doi: 10.1016/j.bbrc.2018.01.079

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Miceli C, Roccio F, Penalva-Mousset L, Burtin M, Leroy C, Nemazanyy I, et al. The primary cilium and lipophagy translate mechanical forces to direct metabolic adaptation of kidney epithelial cells. Nat Cell Biol (2020) 22(9):1091–102. doi: 10.1038/s41556-020-0566-0

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Martinez-Lopez N, Singh R. Shear stress turns on the primary cilium and lipophagy. Nat Cell Biol (2020) 22(9):1029–30. doi: 10.1038/s41556-020-0571-3

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Pampliega O, Orhon I, Patel B, Sridhar S, Diaz-Carretero A, Beau I, et al. Functional interaction between autophagy and ciliogenesis. Nature (2013) 502(7470):194–200. doi: 10.1038/nature12639

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Orhon I, Dupont N, Zaidan M, Boitez V, Burtin M, Schmitt A, et al. Primary-cilium-dependent autophagy controls epithelial cell volume in response to fluid flow. Nat Cell Biol (2016) 18(6):657–67. doi: 10.1038/ncb3360

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Brown JM, Witman GB. Cilia and diseases. Bioscience (2014) 64(12):1126–37. doi: 10.1093/biosci/biu174

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Chavali PL, Putz M, Gergely F. Small organelle, big responsibility: the role of centrosomes in development and disease. Philos Trans R Soc Lond B Biol Sci (2014) 369(1650). doi: 10.1098/rstb.2013.0468

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Sharma N, Berbari NF, Yoder BK. Ciliary dysfunction in developmental abnormalities and diseases. Curr Top Dev Biol (2008) 85:371–427. doi: 10.1016/S0070-2153(08)00813-2

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Fliegauf M, Benzing T, Omran H. When cilia go bad: cilia defects and ciliopathies. Nat Rev Mol Cell Biol (2007) 8(11):880–93. doi: 10.1038/nrm2278

PubMed Abstract | CrossRef Full Text | Google Scholar

46. McConnachie DJ, Stow JL, Mallett AJ. Ciliopathies and the kidney: A review. Am J Kidney Dis (2021) 77(3):410–9. doi: 10.1053/j.ajkd.2020.08.012

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Santoni M, Piva F, Cimadamore A, Giulietti M, Battelli N, Montironi R, et al. Exploring the spectrum of kidney ciliopathies. Diagn (Basel) (2020) 10(12). doi: 10.3390/diagnostics10121099

CrossRef Full Text | Google Scholar

48. Barroso-Gil M, Olinger E, Sayer JA. Molecular genetics of renal ciliopathies. Biochem Soc Trans (2021) 49(3):1205–20. doi: 10.1042/BST20200791

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Deane JA, Ricardo SD. Polycystic kidney disease and the renal cilium. Nephrol (Carlton) (2007) 12(6):559–64. doi: 10.1111/j.1440-1797.2007.00869.x

CrossRef Full Text | Google Scholar

50. Boucher C, Sandford R. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). Eur J Hum Genet (2004) 12(5):347–54. doi: 10.1038/sj.ejhg.5201162

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet (2003) 33(2):129–37. doi: 10.1038/ng1076

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Dell KM. The role of cilia in the pathogenesis of cystic kidney disease. Curr Opin Pediatr (2015) 27(2):212–8. doi: 10.1097/MOP.0000000000000187

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Guay-Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: the clinical experience in north America. Pediatrics (2003) 111(5 Pt 1):1072–80. doi: 10.1542/peds.111.5.1072

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Hildebrandt F, Attanasio M, Otto E. Nephronophthisis: disease mechanisms of a ciliopathy. J Am Soc Nephrol (2009) 20(1):23–35. doi: 10.1681/ASN.2008050456

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Pazour GJ, Dickert BL, Vucica Y, Seeley ES, Rosenbaum JL, Witman GB, et al. Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J Cell Biol (2000) 151(3):709–18. doi: 10.1083/jcb.151.3.709

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Lin F, Hiesberger T, Cordes K, Sinclair AM, Goldstein LS, Somlo S, et al. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc Natl Acad Sci U.S.A. (2003) 100(9):5286–91. doi: 10.1073/pnas.0836980100

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Jonassen JA, San Agustin J, Follit JA, Pazour GJ. Deletion of IFT20 in the mouse kidney causes misorientation of the mitotic spindle and cystic kidney disease. J Cell Biol (2008) 183(3):377–84. doi: 10.1083/jcb.200808137

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Nachury MV, Loktev AV, Zhang Q, Westlake CJ, Peranen J, Merdes A, et al. A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell (2007) 129(6):1201–13. doi: 10.1016/j.cell.2007.03.053

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Watnick T, Germino G. From cilia to cyst. Nat Genet (2003) 34(4):355–6. doi: 10.1038/ng0803-355

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Hansen JN, Kaiser F, Leyendecker P, Stuven B, Krause JH, Derakhshandeh F, et al. A cAMP signalosome in primary cilia drives gene expression and kidney cyst formation. EMBO Rep (2022) 23:e54315. doi: 10.15252/embr.202154315

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet (2005) 365(9457):417–30. doi: 10.1016/S0140-6736(05)70238-5

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Rosen S, Stillman IE. Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. J Am Soc Nephrol (2008) 19(5):871–5. doi: 10.1681/ASN.2007080913

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Verghese E, Ricardo SD, Weidenfeld R, Zhuang J, Hill PA, Langham RG, et al. Renal primary cilia lengthen after acute tubular necrosis. J Am Soc Nephrol (2009) 20(10):2147–53. doi: 10.1681/ASN.2008101105

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Verghese E, Weidenfeld R, Bertram JF, Ricardo SD, Deane JA. Renal cilia display length alterations following tubular injury and are present early in epithelial repair. Nephrol Dial Transplant (2008) 23(3):834–41. doi: 10.1681/ASN.2008101105

PubMed Abstract | CrossRef Full Text | Google Scholar

65. D'Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol (2003) 23(2):117–34. doi: 10.1053/snep.2003.50012

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Huynh Cong E, Bizet AA, Boyer O, Woerner S, Gribouval O, Filhol E, et al. A homozygous missense mutation in the ciliary gene TTC21B causes familial FSGS. J Am Soc Nephrol (2014) 25(11):2435–43. doi: 10.1681/ASN.2013101126

PubMed Abstract | CrossRef Full Text | Google Scholar

67. Solic I, Racetin A, Filipovic N, Mardesic S, Bocina I, Galesic-Ljubanovic D, et al. Expression pattern of alpha-tubulin, inversin and its target dishevelled-1 and morphology of primary cilia in normal human kidney development and diseases. Int J Mol Sci (2021) 22(7). doi: 10.3390/ijms22073500

CrossRef Full Text | Google Scholar

68. Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers (2020) 6(1):7. doi: 10.1038/s41572-019-0141-9

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Larsen TE, Ghadially FN. Cilia in lupus nephritis. J Pathol (1974) 114(2):69–73. doi: 10.1002/path.1711140203

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Shahbazian H, Rezaii I. Diabetic kidney disease; review of the current knowledge. J Renal Inj Prev (2013) 2(2):73–80. doi: 10.12861/jrip.2013.24

PubMed Abstract | CrossRef Full Text | Google Scholar

71. Tonneijck L, Muskiet MH, Smits MM, van Bommel EJ, Heerspink HJ, van Raalte DH, et al. Glomerular hyperfiltration in diabetes: Mechanisms, clinical significance, and treatment. J Am Soc Nephrol (2017) 28(4):1023–39. doi: 10.1681/ASN.2016060666

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Premaratne E, Verma S, Ekinci EI, Theverkalam G, Jerums G, MacIsaac RJ. The impact of hyperfiltration on the diabetic kidney. Diabetes Metab (2015) 41(1):5–17. doi: 10.1016/j.diabet.2014.10.003

PubMed Abstract | CrossRef Full Text | Google Scholar

73. Zhang G, Darshi M, Sharma K. The warburg effect in diabetic kidney disease. Semin Nephrol (2018) 38(2):111–20. doi: 10.1016/j.semnephrol.2018.01.002

PubMed Abstract | CrossRef Full Text | Google Scholar

74. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res (2010) 107(9):1058–70. doi: 10.1161/CIRCRESAHA.110.223545

PubMed Abstract | CrossRef Full Text | Google Scholar

75. Hong Q, Zhang L, Das B, Li Z, Liu B, Cai G, et al. Increased podocyte sirtuin-1 function attenuates diabetic kidney injury. Kidney Int (2018) 93(6):1330–43. doi: 10.1016/j.kint.2017.12.008

PubMed Abstract | CrossRef Full Text | Google Scholar

76. Lam HC, Cloonan SM, Bhashyam AR, Haspel JA, Singh A, Sathirapongsasuti JF, et al. Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction. J Clin Invest (2013) 123(12):5212–30. doi: 10.1172/JCI69636

PubMed Abstract | CrossRef Full Text | Google Scholar

77. Arjumand W, Sultana S. Role of VHL gene mutation in human renal cell carcinoma. Tumour Biol (2012) 33(1):9–16. doi: 10.1007/s13277-011-0257-3

PubMed Abstract | CrossRef Full Text | Google Scholar

78. Schraml P, Frew IJ, Thoma CR, Boysen G, Struckmann K, Krek W, et al. Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Mod Pathol (2009) 22(1):31–6. doi: 10.1038/modpathol.2008.132

PubMed Abstract | CrossRef Full Text | Google Scholar

79. Hassounah NB, Nagle R, Saboda K, Roe DJ, Dalkin BL, McDermott KM. Primary cilia are lost in preinvasive and invasive prostate cancer. PloS One (2013) 8(7):e68521. doi: 10.1371/journal.pone.0068521

PubMed Abstract | CrossRef Full Text | Google Scholar

80. Seeley ES, Carriere C, Goetze T, Longnecker DS, Korc M. Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia. Cancer Res (2009) 69(2):422–30. doi: 10.1158/0008-5472.CAN-08-1290

PubMed Abstract | CrossRef Full Text | Google Scholar

81. Menzl I, Lebeau L, Pandey R, Hassounah NB, Li FW, Nagle R, et al. Loss of primary cilia occurs early in breast cancer development. Cilia (2014) 3:7. doi: 10.1186/2046-2530-3-7

PubMed Abstract | CrossRef Full Text | Google Scholar

82. Egeberg DL, Lethan M, Manguso R, Schneider L, Awan A, Jorgensen TS, et al. Primary cilia and aberrant cell signaling in epithelial ovarian cancer. Cilia (2012) 1(1):15. doi: 10.1186/2046-2530-1-15

PubMed Abstract | CrossRef Full Text | Google Scholar

83. Pak E, Segal RA. Hedgehog signal transduction: Key players, oncogenic drivers, and cancer therapy. Dev Cell (2016) 38(4):333–44. doi: 10.1016/j.devcel.2016.07.026

PubMed Abstract | CrossRef Full Text | Google Scholar

84. Hassounah NB, Nunez M, Fordyce C, Roe D, Nagle R, Bunch T, et al. Inhibition of ciliogenesis promotes hedgehog signaling, tumorigenesis, and metastasis in breast cancer. Mol Cancer Res (2017) 15(10):1421–30. doi: 10.1158/1541-7786.MCR-17-0034

PubMed Abstract | CrossRef Full Text | Google Scholar

85. Amakye D, Jagani Z, Dorsch M. Unraveling the therapeutic potential of the hedgehog pathway in cancer. Nat Med (2013) 19(11):1410–22. doi: 10.1038/nm.3389

PubMed Abstract | CrossRef Full Text | Google Scholar

86. Pala R, Mohieldin AM, Sherpa RT, Kathem SH, Shamloo K, Luan Z, et al. Ciliotherapy: Remote control of primary cilia movement and function by magnetic nanoparticles. ACS Nano (2019) 13(3):3555–72. doi: 10.1021/acsnano.9b00033

PubMed Abstract | CrossRef Full Text | Google Scholar

87. Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-cas gene editing. Nat Nanotechnol (2020) 15(4):313–20. doi: 10.1038/s41565-020-0669-6

PubMed Abstract | CrossRef Full Text | Google Scholar

88. Micelli C, Rastelli G. Histone deacetylases: structural determinants of inhibitor selectivity. Drug Discovery Today (2015) 20(6):718–35. doi: 10.1016/j.drudis.2015.01.007

PubMed Abstract | CrossRef Full Text | Google Scholar

89. Kalin JH, Bergman JA. Development and therapeutic implications of selective histone deacetylase 6 inhibitors. J Med Chem (2013) 56(16):6297–313. doi: 10.1021/jm4001659

PubMed Abstract | CrossRef Full Text | Google Scholar

90. West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. J Clin Invest (2014) 124(1):30–9. doi: 10.1172/JCI69738

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: primary cilium, kidney development, renal disease, renal function, ciliopathy

Citation: Bai Y, Wei C, Li P, Sun X, Cai G, Chen X and Hong Q (2022) Primary cilium in kidney development, function and disease. Front. Endocrinol. 13:952055. doi: 10.3389/fendo.2022.952055

Received: 24 May 2022; Accepted: 02 August 2022;
Published: 22 August 2022.

Edited by:

Congjuan Luo, The Affiliated Hospital of Qingdao University, China

Reviewed by:

Dongshan Zhang, Second Xiangya Hospital, Central South University, China
Kun Ling Ma, Zhejiang University, China

Copyright © 2022 Bai, Wei, Li, Sun, Cai, Chen and Hong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiangmei Chen, eG1jaGVuMzAxQDEyNi5jb20=; Quan Hong, aG9uZ3F1YW5AMzAxaG9zcGl0YWwuY29tLmNu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.